Archive for the ‘faked data’ Category
Here’s a prime example of the consequences of that bureaucratic foot-dragging: Ten months after being told that Fazlurrahman Khan had fabricated his data, and two months after announcing two of Khan’s papers would be retracted from two of its journals, Elsevier still has not retracted either paper.
Worse, at least one of the papers, “Degradation of 2,4-dinitroanisole (DNAN) by metabolic cooperative activity of Pseudomonas sp. strain FK357 and Rhodococcus imtechensis strain RKJ300,” in the journal Chemosphere, has been cited since the announcement was made. In fact, the paper was published in Journal of Hazardous Materials, the Elsevier journal that is dragging its feet retracting another of Khan’s papers, “Aerobic degradation of 4-nitroaniline (4-NA) via novel degradation intermediates by Rhodococcus sp. strain FK48.”
Karel Bezouška, a researcher who broke into a lab refrigerator to tamper with an investigation into his work, has nine retractions.
Here’s the retraction notice in Biochemistry for 2010’s “Cooperation between Subunits Is Essential for High-Affinity Binding of N-Acetyl-d-hexosamines to Dimeric Soluble and Dimeric Cellular Forms of Human CD69:” Read the rest of this entry »
The article was titled “In vitro neutralization of HCV by goat antibodies against peptides encompassing regions downstream of HVR-1 of E2 glycoprotein.” According to the abstract: Read the rest of this entry »
Want bogus data, million-dollar fraud allegations and a scientist on the lam? We give you Alain Malafosse.
The British Journal of Psychiatry has retracted a June 2013 paper by Malafosse and his colleagues on the genetics of bipolar disorder in children because Malafosse allegedly fabricated key data in the study.
The article, “Childhood maltreatment and methylation of the glucocorticoid receptor gene NR3C1 in bipolar disorder,” purported to find that people with bipolar disorder who had experienced more, and more severe, abuse early in life were more likely to show epigenetic changes. According to the abstract:
The paper, “The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells,” was initially published in September 2011 and has been cited 25 times, according to Thomson Scientific’s Web of Knowledge. First author Jiyeon Kim was an MD-PhD candidate at the University of Pennsylvania until this year, according to a LinkedIn profile.
Nasser Chegini, an ob-gyn formerly on the faculty at the University of Florida who has been the subject of an Office of Research Integrity (ORI) inquiry for several years, has a second retraction.
Chegini is suspected of having used bogus data in some of his work — research backed in part by some $4 million in federal funding.